
Published
04 October 2011 | By CoreLab Partners
Whether your prospective compound or novel radiotracer is in the early or late stage of trial development, CoreLab Partners' Molecular Imaging services can be leveraged to successfully gather, analyze, and deliver crucial functional imaging data. For early phase trials, we work with you to provide highquality imaging efficacy data that empowers you to expedite critical go/no-go decisions. Your project team will be able to identify ineffective compounds earlier, saving valuable time and resources, while allowing only your most promising compounds to advance in your drug-development pipeline.
As a registered user of PBR you can skip the majority of this form. Registration is FREE so register now or log in if you're already a member.
Fill In Details
By clicking the 'download white paper' button you agree to pass your details as shown to the white paper advertiser. The enquirer also permits the advertiser to follow up the enquiry by phone or email. PBR is in no way responsible for further communication between parties.
Fields marked * are compulsory
Fields marked * are compulsory